WindMIL Therapeutics
closedWindMIL Therapeutics is developing cell therapies for oncology indications.
Launch date
Employees
Market cap
-
Enterprise valuation
€118—177m (Dealroom.co estimates Jun 2018.)
Princeton New Jersey (HQ)
Authorizing premium user...